Gene Name |
interleukin enhancer binding factor 3, 90kDa |
splicing factor 3b, subunit 4, 49kDa |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
26 interactors:
DHX9
EIF2AK2
ERG
FUS
GDF9
HNRNPH2
IL7R
KRTAP4-12
LNX1
MAGEA11
MDFI
NDRG1
PLSCR1
PRMT1
RBM5
RBPMS
RNF113A
SF1
SF3B4
SMN1
SNRPC
TRIP6
XAB2
XPO5
ZNF346
ZNF830
|
42 interactors:
APBB1
BAG3
BAIAP2
BMPR1A
CHERP
CWF19L2
DDX17
DDX42
EFTUD2
EWSR1
FKBP1A
FRK
GRB2
HNRNPD
HNRNPF
HNRNPH1
HNRNPUL1
HSPB7
ILF3
ITSN1
MAPK9
METTL17
NCK2
NUB1
PPP1R16B
PRPF40A
RBM39
RBM4
SEC24D
SF1
SF3B2
SRSF6
SS18L1
STK19
SUMO4
TCAF1
TCERG1
UBASH3A
UBC
WBP4
WDR77
ZCCHC10
|
Entrez ID |
3609 |
10262 |
HPRD ID |
04420 |
12028 |
Ensembl ID |
ENSG00000129351
|
ENSG00000143368
|
Uniprot IDs |
Q12906
|
B3KUJ0
Q15427
|
PDB IDs |
2L33
3P1X
|
1X5T
1X5U
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
acting
analogues
axis
cll
cytotoxicity
dca
dichloroacetate
emphasize
exhibits
harboring
hl
indeed
invariably
knocking
leukemic
lymphocytic
maver
mec
mediating
merits
options
p21
p53mutated
p53null
p53wild
proteomic
purine
sirnas
underscored
|
|
Tagcloud (Difference) ? |
acting
analogues
axis
cll
cytotoxicity
dca
dichloroacetate
emphasize
exhibits
harboring
hl
indeed
invariably
knocking
leukemic
lymphocytic
maver
mec
mediating
merits
options
p21
p53mutated
p53null
p53wild
proteomic
purine
sirnas
underscored
|
|
Tagcloud (Intersection) ? |
|